Valuation: DNA X, Inc.

Market Cap 5.05M 4.41M 4.07M 3.75M 7.07M 486M 7.23M 48.63M 19.13M 238M 18.95M 18.53M 819M P/E 2024
-0.44x
P/E 2025 -0.11x
Enterprise Value 8.81M 7.7M 7.1M 6.55M 12.34M 848M 12.61M 84.89M 33.39M 415M 33.08M 32.35M 1.43B EV / Sales 2024
0.17x
EV / Sales 2025 -
Free-Float
63.9%
Yield 2024 *
-
Yield 2025 -
1 day-1.74%
1 week-16.30%
Current month-34.17%
1 month-27.87%
3 months+13.00%
6 months-27.87%
Current year+7.62%
1 week 3
Extreme 3
4.43
1 month 3
Extreme 3
6.14
Current year 2.62
Extreme 2.62
7.97
1 year 2.52
Extreme 2.5211
16.97
3 years 2.52
Extreme 2.5211
198
5 years 2.52
Extreme 2.5211
1,322.28
10 years 2.52
Extreme 2.5211
32,863.47
Manager TitleAgeSince
Chief Executive Officer 63 2026-02-08
Director of Finance/CFO 64 2022-07-12
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 63 2023-11-12
Director/Board Member 64 2022-07-12
Director/Board Member 79 2022-07-12
Date Insider Type Main position Quantity % Market Cap.
2/9/26 Free

Chief Executive Officer

50,000 3.3592%
2/9/26 Free

Chief Financial Officer

35,000 2.3514%
7/18/25 Other

Director

723 0.0053%
Change 5-day change 1-year change 3-year change Capi.($)
-1.74%-16.30%-75.98%-98.29% 5.05M
-8.77%-10.53%+282.31%+247.89% 1,083B
-3.91%+2.71%-26.02%+19.11% 1.66B
+0.17%-0.34%+15.60%+308.05% 1.2B
-5.31%-9.08%-3.86%-29.83% 1.06B
-2.56%-6.88%+67.68%+44.75% 1.04B
-5.02%-12.97%-10.09%+71.27% 596M
+0.88%+8.70%-5.92%+155.52% 541M
-8.86%-13.04%+6.19%-15.69% 398M
-0.70%-6.68%-19.46%+286.96% 176M
Average -3.58%-5.45%+23.05%+98.97% 108.95B
Weighted average by Cap. -8.74%-10.48%+280.61%+246.90%

Financials

2024 2025
Net sales 58.3M 50.95M 47.01M 43.33M 81.68M 5.61B 83.49M 562M 221M 2.75B 219M 214M 9.47B -
Net income -33.65M -29.4M -27.13M -25.01M -47.14M -3.24B -48.19M -324M -128M -1.59B -126M -124M -5.46B -20.66M -18.05M -16.66M -15.35M -28.94M -1.99B -29.58M -199M -78.31M -974M -77.58M -75.88M -3.35B
Net Debt -5.34M -4.67M -4.31M -3.97M -7.49M -515M -7.65M -51.5M -20.26M -252M -20.07M -19.63M -868M 3.76M 3.29M 3.03M 2.8M 5.27M 362M 5.39M 36.26M 14.26M 177M 14.13M 13.82M 611M
Logo DNA X, Inc.
DNA X, Inc., formerly Sonim Technologies, Inc., is a digital asset management platform, building on the digital asset trading platform. The Company operates an artificial intelligence (AI) and crypto trading platform designed to automate trading strategies using machine learning technologies. It provides a digital asset trading platform that allows users to trade or swap cryptocurrencies for other cryptocurrencies or cash equivalent currencies. The Company’s DNA X trading website enables users to implement strategies to take advantage of fluctuations in relative values of cryptocurrency pairs. The platform allows users to set up automated trading strategies, monitor other traders’ trading strategies in real time, and simulate trades. The Company generates revenue from trading commissions based on the value of trades executed on its platform. It serves individual investors from around the world and supports its operations through subsidiaries located in China, Germany, and Hong Kong.
Employees
4
Date Price Change Volume
26-07-17 US$3.390 -1.74% 44,164
26-07-16 US$3.450 -6.50% 23,076
26-07-15 US$3.690 -14.78% 64,746
26-07-14 US$4.330 -0.23% 45,625
26-07-13 US$4.340 +7.16% 18,088

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SONM Stock